
Results
2
Companies which are potentially undervalued and in an acceptable financial position.
2 companies
Krka d. d
Market Cap: €7.1b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€234.00
7D
0.4%
1Y
42.7%
Nova Ljubljanska Banka d.d
Market Cap: €3.8b
Provides various banking services for retail and corporate clients in Slovenia, South East Europe, and Western Europe.
NLBR
€192.00
7D
3.5%
1Y
36.2%